Research · PMID 38888619

PubMed sourcedAbstract-based analysis

Reviewed by Neal Rouzier, MD, Preventive Medicine · Sep 2026

Menopause and brain fog: how to counsel and treat midlife women.

Menopause (New York, N.Y.) · July 2024 · Pauline M Maki, Nicole G Jaff

What this study found

Brain fog, referring to menopause-related subjective cognitive difficulties, is common in midlife women. Longitudinal studies find small but reliable declines in objective memory performance as women transition into perimenopause, and these are not explained by advancing age alone.

unknown

How RAGMD uses this study

Clinical questions this paper informs

Synthesis lives on the evidence question — this page shows where the study sits in that analysis.

Core study

Is menopause associated with cognitive changes or brain fog?

Many women report subjective cognitive difficulty during perimenopause, often linked to sleep disruption and vasomotor symptoms. Objective cognitive testing shows subtle changes in some cohorts, but HRT is not established as a treatment for brain fog alone.

Open evidence analysis

Supporting literature

What therapies are most effective for vasomotor symptoms in perimenopause?

Systemic hormone therapy remains the most effective treatment for moderate-to-severe vasomotor symptoms across the menopause transition. When estrogen is declined or contraindicated, evidence-supported non-hormonal options—including fezolinetant and selected SSRIs/SNRIs—reduce symptoms, though with generally smaller effect than estrogen.

Open evidence analysis

Supporting literature

Is fezolinetant effective for menopausal hot flashes?

Fezolinetant, a neurokinin-3 receptor antagonist, reduced moderate-to-severe vasomotor symptoms in randomized trials of postmenopausal women. It offers a non-hormonal option when estrogen is contraindicated or declined.

Open evidence analysis

Supporting literature

Does hormone therapy improve sleep disturbance in menopause?

Menopausal hormone therapy can improve sleep when vasomotor symptoms are a major driver of disruption. Benefits for primary insomnia without hot flashes are less consistent across trials.

Open evidence analysis

Supporting literature

Does hormone therapy help depression or anxiety during perimenopause?

Some trials suggest estrogen-based therapy may help depressive symptoms during the menopause transition, particularly when vasomotor symptoms coexist. It is not a substitute for standard treatment of major depressive disorder.

Open evidence analysis

Supporting literature

Does menopause cause weight gain and can hormone therapy help?

Menopause is associated with central adiposity and lean mass loss independent of aging alone. Hormone therapy is not a weight-loss treatment but may attenuate some menopause-related body composition shifts in selected women.

Open evidence analysis